$16.58
-0.43-2.53%
At close: May 6, 5:00 PM EST
$16.70
-0.31-1.82%
Pre-Market: 3:00 AM EST
Burning Rock Biotech Ltd Stock Guidance
BNRNASDAQ
Burning Rock Biotech (BNR) last issued guidance on May 30, 2023 for fiscal year 2023. The company guided revenue in the range of $97.99M - $97.99M for the period.
Compared to prior guidance, Burning Rock Biotech maintained its revenue forecast from a prior range of $97.99M - $97.99M.
Burning Rock Biotech has issued 6 guidance updates between May 31, 2022 and May 30, 2023. During this period, the company raised its outlook 2 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
May 30, 2023
Guidance Period
Full Year 2023
Revenue Guidance Range
$97.99M - $97.99M
Burning Rock Biotech Guidance History
Review all historical guidance issued by Burning Rock Biotech, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Burning Rock Biotech (BNR)?
The most recent guidance for Burning Rock Biotech (BNR) was reported on May 30, 2023 for the fiscal year 2023. Burning Rock Biotech forecasted revenue between $97.99M and $97.99M for the period.
What revenue range did Burning Rock Biotech (BNR) guide for?
Burning Rock Biotech (BNR) guided revenue in the range of $97.99M to $97.99M for the fiscal year 2023.
Did Burning Rock Biotech (BNR) raise or lower guidance?
Burning Rock Biotech (BNR) maintained its revenue guidance from a prior range of $97.99M - $97.99M to $97.99M - $97.99M for the fiscal year 2023.
When did Burning Rock Biotech (BNR) last issue guidance?
Burning Rock Biotech (BNR) last issued guidance on May 30, 2023 for the fiscal year 2023.
